从NOTION到细微差别:低风险患者的TAVR和SAVR
1Department of Cardiac Surgery, Rabindranath Tagore International Institute of Cardiac Sciences, Narayana Health, 124, EM Bypass, Mukundapur, Kolkata, 700099 India.
Indian journal of thoracic and cardiovascular surgery
|April 29, 2024
概括
这是一项NOTION试验.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 过导管的大动脉置换 (TAVR) 和外科大动脉置换 (SAVR) 是大动脉狭窄的关键治疗方法.
- 低风险患者代表着对大动脉干预的越来越多的人群.
研究的目的:
- 为了比较TAVR与SAVR在患有严重大动脉狭窄症的低风险患者的10年结局.
- 评估TAVR和SAVR之间的安全性,疗效和与设备相关的性能.
主要方法:
- NOTION试验是一个前性,随机对照试验.
- 分析了10年随访数据的死亡率,中风,心肌梗塞和门性能.
- 结果由一个不盲目的委员会评估.
主要成果:
- 死亡率,中风和心肌梗塞率在TAVR和SAVR之间在10年内是相似的.
- TAVR显示有效孔面积改善和更低的跨假肢梯度.
- 在TAVR中,永久心脏起器植入和准膜泄漏率较高,但新发性心房动率较低.
结论:
- 在低风险患者中,TAVR和SAVR都提供类似的长期存活率和临床结果.
- TAVR显示出有利的血液动力学,但需要仔细考虑起器需求和准膜泄漏风险.
- 需要进行进一步的研究,以解决解盲的概括性和潜在偏见.
相关概念视频
Standards of Care II
Nurses bear specific legal responsibilities under several federal statutes, including:
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Drug Dosage Regimen: Overview
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...


